Jerzy M.
- Country
- Poland
- Department
- Mackiewicz Okulistyka Sp.z o.o.
Research Overview
- Phase III Randomized Double‑Masked Sham‑Controlled Trial of Intravitreal IL6‑Mab in Patients with Uveitic Macular Edema
- A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 to Aflibercept in Participants with Diabetic Macular Edema
- Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
Data & Insights
Has run more than one trial at 45 of 154 partner sites.
Specializations
Ophthalmology Specialization
This investigator focuses on advanced treatments for severe ocular conditions, particularly in the field of retinal diseases and macular disorders.
- Neovascular Age-related Macular Degeneration
- Uveitic Macular Edema
- Visual Acuity Assessment
The investigator specializes in evaluating novel therapeutic approaches for macular pathologies.
Therapeutic Expertise
Primary research interest centers on intravitreal treatments and innovative therapeutic combinations for ocular conditions.
- Combined Therapy Approaches
- Intravitreal Administration
- Novel Therapeutic Agents
The investigator explores innovative treatment modalities for complex retinal disorders.
Clinical Focus Areas
Specialized in treating patients with advanced retinal conditions requiring targeted therapeutic interventions.
- Vision Function Assessment
- Macular Disease Management
- Retinal Therapeutics
The investigator works with emerging treatments for macular pathologies affecting visual acuity.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.